key: cord-0792088-u3r2cssb
authors: Çavdaroğlu, Sude; Hasan, Mohammad Mehedi; Mohan, Anmol; Xenophontos, Eleni; Costa, Ana Carla dos Santos; Aborode, Abdullahi T.; Tsagkaris, Christos; Outani, Oumaima; Ahmad, Shoaib; Essar, Mohammad Yasir
title: The spread of Yellow fever amidst the COVID‐19 pandemic in Africa and the ongoing efforts to mitigate it
date: 2021-05-04
journal: J Med Virol
DOI: 10.1002/jmv.27027
sha: d6288fb529a90e681727685ca87bb12451273346
doc_id: 792088
cord_uid: u3r2cssb

nan

The spread of Yellow fever amidst the COVID-19 pandemic in Africa and the ongoing efforts to mitigate it To the Editor, Yellow fever (YF), a viral illness transmitted by Aedes and Haemagogus mosquitoes, is a severe public health concern in countries of Sub-Saharan Africa. It can manifest itself in several ways, from a selflimited, mild febrile illness to serious hemorrhage and liver disease. 1 Large epidemics of YF occur when infected individuals spread the virus to densely populated areas with high mosquito densities and where the majority of people lack immunity due to a lack of vaccination. In these situations, infected mosquitos spread the virus from person to person.

In Africa, 27 countries are at the greatest risk of yellow fever epidemics. YF is thought to affect 84,000-170,000 people in Africa each year, with 29,000-60,000 deaths. In 2016, 965 cases of YF were confirmed, and about 400 people died in two related urban YF outbreaks in Angola and the Democratic Republic of the Congo. The outbreak necessitated the manufacture of more than 28 million doses of YF vaccine, depleting the global vaccine supply. It also diverted public health officials' focus away from other problems impacting health systems. 2 Since YF virus infects a multitude of primates by a plethora of vectors, parallel pools of transmission take place. The preventive strategies against YF are based on the vaccines, which fortunately exist for decades, and on the elimination of mosquito breeding grounds. Despite the tons of efforts put into by the local authorities and the WHO efforts to eliminate the disease by launching ambitious vaccination programs, vaccination against YF is still not at the expected levels. A study done in Nigeria stated that low vaccine uptake has caused an outbreak in 2019. The study suggests that low vaccination rates were due to not seeking medical attention priorly. 3 As in other countries in the world, such as Brazil, 4-6 India, 7 Therefore, YF has been increasing its incidence in Africa for the last years and it is considered a re-emerging disease. For this reason, not only African authorities but also international institutions are taking action for its control and prevention by mobilizing resources, forming global collaborations, and strategies implementing the principle of prevention while there's no treatment for YF. 16 Since effective vaccination for YF is developed, efforts begin from immunization. Mass immunization is implemented in high-risk areas for the control and prevention of outbreaks and regional For that reason, WHO provides technical support to the African government, guidance on integrating YF, trains teams to conduct large-scale campaigns, and assists in increasing national laboratory capacities. Also, to ensure rapid response to outbreaks in high-risk countries, the International Coordinating group maintains an emergency stockpile of YF vaccines.

Finally, international initiatives such as the Eliminate Yellow Fever Epidemics Strategy bring countries together to tackle the increased risk of YF in a coordinated manner, and it is an opportunity for demonstrating new ways of managing re-emerging infectious diseases.

All the authors declare that there are no conflict of interests. 

Culture matrix configuration and composition in the maintenance of hepatocyte polarity and function

Yellow Fever | WHO | Regional Office for Africa

Delay in health-seeking behaviour: Implication to yellow fever outcome in the 2019 outbreak in Nigeria. Heal Soc Care Community

Chikungunya and COVID-19 in Brazil: the danger of an overlapping crises

2021:jmv.26952

Dengue and COVID-19: a double burden to Brazil

COVID-19 and Zika: an emerging dilemma for Brazil

Dengue amidst COVID-19 in India: the mystery of plummeting cases

A skeleton in the closet: the implications of COVID-19 on XDR strain of typhoid in Pakistan

MSF. Yellow fever in depth | MSF

UNDP: In Ethiopia, pandemic struck amid slowing growth, locust invasion, and disease outbreaks | Africa Renewal

s community nurses deliver child health care amid COVID-19 | Africa Renewal

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised. Double-Blind, Non-Inferiority Trial

Evaluation of patient characteristics, management and outcomes for COVID-19 at district hospitals in the Western Cape, South Africa: descriptive observational study

Lockdown measures in response to COVID-19 in nine sub-Saharan African countries